Fund details
Life sciences-focused early-stage firm investing in discoveries with the potential to prevent, detect, and cure diseases.
Go to profile
Partners related to this fund
Kristina Burow
Managing Director
Ms. Burow is managing director at Arch, focused on biotech, pharmaceutical, and health tech companies. She serves on the boards of Beam Therapeutics, Scholar Rock, and others, and has been instrumental in Arch's billion-dollar portfolio. Ms. Burow holds an MBA from the University of Chicago and degrees in chemistry from Columbia University and UC Berkeley.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Target regions
USA
Investment ranges
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Not found
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Investors targeting related sectors
No partner found.
.svg)
